Skip to main content
. 2013 Apr;20(4):491–500. doi: 10.1128/CVI.00577-12

Table 2.

Serum anti-hemagglutinin antibody in chickens immunized with pCAG-HA DNA vaccine carrying the hemagglutinin gene of avian influenza virus strain A/Hanoi/30408/2005 (H5N1) as measured by a competitive ELISA

Vaccine dose (μg) + Electroporation
− Electroporation
Vaccinated birds
Seroconversion during the course of expt
Vaccinated birds
Seroconversion during the course of expt
Total no. Median % inhibition Range of inhibition (%) No. of seropositive birds/total no. immunized Earliest detection, (avg dpv)a Antibody persistence (avg no. of days)b Total no. Median % inhibition Range of inhibition (%) No. of seropositive birds/total no. immunized Earliest detection, (avg dpv)a Antibody persistence (avg no. of days)
0 5 3 0–9 0/5 Not detected 0 10 0 0 0/10 Not detected 0
10 13 48 3–99 6/13 42 10 13 9 0–36 0/13 Not detected 0
100 12 85 29–101 11/12 31 26 12 12 0–47 0/12 Not detected 0
250 5 96 58–99 5/5 29 26 5 17 1–24 0/5 Not detected 0
a

Not detected: none of the chickens tested positive at any of the sampling times. Serum with a cELISA inhibition value of ≥50% was considered positive.

b

The study design allowed only for measuring antibody persistence to a maximum of 43 days before termination of experiment.